Interline Therapeutics’ $92 million Series Seed and Series A financing

Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Interline Therapeutics on the deal.Interline Therapeutics, a data science and healthcare company, announced its $92 million Series Seed…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now